SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-17-211889
Filing Date
2017-06-23
Accepted
2017-06-23 17:04:14
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3 d409015ds3.htm S-3 122016
2 EX-5.1 d409015dex51.htm EX-5.1 4520
3 EX-23.1 d409015dex231.htm EX-23.1 1506
4 EX-23.2 d409015dex232.htm EX-23.2 1780
  Complete submission text file 0001193125-17-211889.txt   130905
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-218949 | Film No.: 17928312
SIC: 2834 Pharmaceutical Preparations